12:00 AM
 | 
Jun 17, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aridol mannitol Bronchial Challenge Test Kit regulatory update

Pharmaxis said FDA placed its Aridol mannitol Bronchial Challenge Test Kit to assess bronchial hyperresponsiveness in patients >=6 years of age who do not have clinically apparent asthma on an import alert list, which prevents the import of the product into...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >